Revolade

Medicinal product

(Invented) name

Revolade

Active substance (s)

Eltrombopagas

Strength

50 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B02BX05, Eltrombopag

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

2010-03-11

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Eltrombopagas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
40071	53808	1053808	lizdinė plokštelė	N14		Receptinis	EU/1/10/612/004	Netiekiama	-	-	No	-	-
40072	53809	1053809	lizdinė plokštelė	N28		Receptinis	EU/1/10/612/005	Netiekiama	-	-	No	-	-
40073	53810	1053810	lizdinė plokštelė	N84 (3x28)		Receptinis	EU/1/10/612/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2010-03-11	Registruotas